Pediatrix Medical (MD) Receivables (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Receivables data on file, last reported at $224.8 million in Q1 2026.

• Receivables for Q1 2026 came in at $224.8 million, down 7.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $224.8 million (down 7.31% YoY), and the FY2025 annual result was $229.7 million, down 20.39% from the prior year.
• Receivables slipped to $224.8 million in Q1 2026 per MD's latest filing, from $229.7 million in the prior quarter.
• Over five years, Receivables peaked at $1.6 billion in Q4 2022 and troughed at $224.8 million in Q1 2026.
• A 5-year average of $761.8 million and a median of $288.5 million in 2024 frame the typical range for Receivables.
• The sharpest annual moves came in 2022 and 2025: Receivables surged 500.93% in 2022, then sank 84.27% in 2025.
• A 5-year view of Receivables shows it stood at $1.6 billion in 2022, then declined by 11.9% to $1.4 billion in 2023, then slumped by 79.57% to $288.5 million in 2024, then slipped by 20.39% to $229.7 million in 2025, then slipped by 2.12% to $224.8 million in 2026.
• Business Quant data shows MD's Receivables at $224.8 million in Q1 2026, $229.7 million in Q4 2025, and $231.1 million in Q3 2025.